Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
Pharma
Bristol CMO touts more ph. 3 wins for bispecific ADC iza-bren
“The data are very supportive,” BMS’ CMO said of a potential global phase 3 for iza-bren in HR+/HER2- breast cancer after a positive China trial.
Angus Liu
Oct 26, 2026 3:30am
Pfizer's Tukysa approved as first-line maintenance therapy
Oct 8, 2026 11:25am
Genentech amplifies breast cancer conversations in new campaign
Oct 1, 2026 2:52pm
Lilly ups oral SERD battle with Inluriyo, Verzenio combo nod
Sep 18, 2026 3:30pm
AZ, Daiichi's Enhertu nabs long-sought NHS blessing from NICE
Sep 16, 2026 7:30pm
AstraZeneca’s Etcamah flunks first-line breast cancer trial
Sep 12, 2026 12:43pm
